159 related articles for article (PubMed ID: 16807238)
21. Hyaluronan synthase 2 (HAS2) regulates cell phenotype and invadopodia formation in luminal-like breast cancer cells.
Sheng Y; Cao M; Liu Y; He Y; Zhang G; Du Y; Gao F; Yang C
Mol Cell Biochem; 2021 Sep; 476(9):3383-3391. PubMed ID: 33954907
[TBL] [Abstract][Full Text] [Related]
22. A novel role of low molecular weight hyaluronan in breast cancer metastasis.
Wu M; Cao M; He Y; Liu Y; Yang C; Du Y; Wang W; Gao F
FASEB J; 2015 Apr; 29(4):1290-8. PubMed ID: 25550464
[TBL] [Abstract][Full Text] [Related]
23. HAS3-related hyaluronan enhances biological activities necessary for metastasis of osteosarcoma cells.
Tofuku K; Yokouchi M; Murayama T; Minami S; Komiya S
Int J Oncol; 2006 Jul; 29(1):175-83. PubMed ID: 16773198
[TBL] [Abstract][Full Text] [Related]
24. Hyaluronan synthase elevation in metastatic prostate carcinoma cells correlates with hyaluronan surface retention, a prerequisite for rapid adhesion to bone marrow endothelial cells.
Simpson MA; Reiland J; Burger SR; Furcht LT; Spicer AP; Oegema TR; McCarthy JB
J Biol Chem; 2001 May; 276(21):17949-57. PubMed ID: 11278609
[TBL] [Abstract][Full Text] [Related]
25. Has2 natural antisense RNA and Hmga2 promote Has2 expression during TGFβ-induced EMT in breast cancer.
Kolliopoulos C; Lin CY; Heldin CH; Moustakas A; Heldin P
Matrix Biol; 2019 Jul; 80():29-45. PubMed ID: 30194979
[TBL] [Abstract][Full Text] [Related]
26. Differential gene expression of TGF-beta family members and osteopontin in breast tumor tissue: analysis by real-time quantitative PCR.
Reinholz MM; Iturria SJ; Ingle JN; Roche PC
Breast Cancer Res Treat; 2002 Jun; 74(3):255-69. PubMed ID: 12206515
[TBL] [Abstract][Full Text] [Related]
27. Role of the integrin-binding protein osteopontin in lymphatic metastasis of breast cancer.
Allan AL; George R; Vantyghem SA; Lee MW; Hodgson NC; Engel CJ; Holliday RL; Girvan DP; Scott LA; Postenka CO; Al-Katib W; Stitt LW; Uede T; Chambers AF; Tuck AB
Am J Pathol; 2006 Jul; 169(1):233-46. PubMed ID: 16816376
[TBL] [Abstract][Full Text] [Related]
28. Induction of hyaluronic acid synthase 2 (HAS2) in human vascular smooth muscle cells by vasodilatory prostaglandins.
Sussmann M; Sarbia M; Meyer-Kirchrath J; Nüsing RM; Schrör K; Fischer JW
Circ Res; 2004 Mar; 94(5):592-600. PubMed ID: 14752026
[TBL] [Abstract][Full Text] [Related]
29. Hyaluronan synthesis and myogenesis: a requirement for hyaluronan synthesis during myogenic differentiation independent of pericellular matrix formation.
Hunt LC; Gorman C; Kintakas C; McCulloch DR; Mackie EJ; White JD
J Biol Chem; 2013 May; 288(18):13006-21. PubMed ID: 23493399
[TBL] [Abstract][Full Text] [Related]
30. A novel ZEB1/HAS2 positive feedback loop promotes EMT in breast cancer.
Preca BT; Bajdak K; Mock K; Lehmann W; Sundararajan V; Bronsert P; Matzge-Ogi A; Orian-Rousseau V; Brabletz S; Brabletz T; Maurer J; Stemmler MP
Oncotarget; 2017 Feb; 8(7):11530-11543. PubMed ID: 28086235
[TBL] [Abstract][Full Text] [Related]
31. Hyaluronan synthase 2 expressed by cancer-associated fibroblasts promotes oral cancer invasion.
Zhang Z; Tao D; Zhang P; Liu X; Zhang Y; Cheng J; Yuan H; Liu L; Jiang H
J Exp Clin Cancer Res; 2016 Nov; 35(1):181. PubMed ID: 27884164
[TBL] [Abstract][Full Text] [Related]
32. Transforming growth factor-beta as a key molecule triggering the expression of versican isoforms v0 and v1, hyaluronan synthase-2 and synthesis of hyaluronan in malignant osteosarcoma cells.
Nikitovic D; Zafiropoulos A; Katonis P; Tsatsakis A; Theocharis AD; Karamanos NK; Tzanakakis GN
IUBMB Life; 2006 Jan; 58(1):47-53. PubMed ID: 16540432
[TBL] [Abstract][Full Text] [Related]
33. Loss of Glycogen Debranching Enzyme AGL Drives Bladder Tumor Growth via Induction of Hyaluronic Acid Synthesis.
Guin S; Ru Y; Agarwal N; Lew CR; Owens C; Comi GP; Theodorescu D
Clin Cancer Res; 2016 Mar; 22(5):1274-83. PubMed ID: 26490312
[TBL] [Abstract][Full Text] [Related]
34. Hyaluronan synthase HAS2 promotes tumor progression in bone by stimulating the interaction of breast cancer stem-like cells with macrophages and stromal cells.
Okuda H; Kobayashi A; Xia B; Watabe M; Pai SK; Hirota S; Xing F; Liu W; Pandey PR; Fukuda K; Modur V; Ghosh A; Wilber A; Watabe K
Cancer Res; 2012 Jan; 72(2):537-47. PubMed ID: 22113945
[TBL] [Abstract][Full Text] [Related]
35. The identification of osteopontin as a metastasis-related gene product in a rodent mammary tumour model.
Oates AJ; Barraclough R; Rudland PS
Oncogene; 1996 Jul; 13(1):97-104. PubMed ID: 8700559
[TBL] [Abstract][Full Text] [Related]
36. PFKFB4 Promotes Breast Cancer Metastasis via Induction of Hyaluronan Production in a p38-Dependent Manner.
Gao R; Liu Y; Li D; Xun J; Zhou W; Wang P; Liu C; Li X; Shen W; Su W; Qiao H; Stupack DG; Luo N
Cell Physiol Biochem; 2018; 50(6):2108-2123. PubMed ID: 30415245
[TBL] [Abstract][Full Text] [Related]
37. Inducible hyaluronan production reveals differential effects on prostate tumor cell growth and tumor angiogenesis.
Bharadwaj AG; Rector K; Simpson MA
J Biol Chem; 2007 Jul; 282(28):20561-72. PubMed ID: 17502371
[TBL] [Abstract][Full Text] [Related]
38. Osteopontin regulates multiple functions contributing to human colon cancer development and progression.
Irby RB; McCarthy SM; Yeatman TJ
Clin Exp Metastasis; 2004; 21(6):515-23. PubMed ID: 15679049
[TBL] [Abstract][Full Text] [Related]
39. The thrombin inhibitor Argatroban reduces breast cancer malignancy and metastasis via osteopontin-dependent and osteopontin-independent mechanisms.
Schulze EB; Hedley BD; Goodale D; Postenka CO; Al-Katib W; Tuck AB; Chambers AF; Allan AL
Breast Cancer Res Treat; 2008 Nov; 112(2):243-54. PubMed ID: 18097747
[TBL] [Abstract][Full Text] [Related]
40. Hyaluronan mediates adhesion of metastatic colon carcinoma cells.
Laurich C; Wheeler MA; Iida J; Neudauer CL; McCarthy JB; Bullard KM
J Surg Res; 2004 Nov; 122(1):70-4. PubMed ID: 15522317
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]